Adoptive Transfer of Serum Samples From Children With Invasive Staphylococcal Infection and Protection Against Staphylococcus aureus Sepsis
- 6 August 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 223 (7) , 1222-1231
Abstract
A successful Staphylococcus aureus vaccine remains elusive, and one controversy in the field is whether humans generate a protective adaptive immune response to infection. We developed a bacterial challenge murine assay that directly assesses the protective capacity of adoptively transferred human serum samples. We first validated the model by showing that postpneumococcal vaccine serum samples from humans induced effective clearance of Streptococcus pneumoniae in mice. We then found that human serum samples adoptively transferred from children with invasive S. aureus infections exhibited protection from disease in a murine model, with some samples conferring near complete protection. These findings demonstrate that human serum samples are capable of conferring a protective adaptive response generated by humans during invasive staphylococcal disease, allowing for the study of protective factors in a murine model. Identification of the protective factors present in the most efficacious serum samples would be of high interest as potential staphylococcal vaccine candidates or passive therapeutics.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health (R01 AI139172, R01 AI127406, R01 144694)
- Ragon Institute
This publication has 46 references indexed in Scilit:
- Extracellular proteases are key mediators of Staphylococcus aureus virulence via the global modulation of virulence‐determinant stabilityMicrobiologyopen, 2012
- Lower Antibody Levels to Staphylococcus aureus Exotoxins Are Associated With Sepsis in Hospitalized Adults With Invasive S. aureus InfectionsThe Journal of Infectious Diseases, 2012
- Inferring Reasons for the Failure of Staphylococcus aureus Vaccines in Clinical TrialsFrontiers in Cellular and Infection Microbiology, 2012
- Expression of Virulence Factors by Staphylococcus aureus Grown in SerumApplied and Environmental Microbiology, 2011
- Global Changes in Staphylococcus aureus Gene Expression in Human BloodPLOS ONE, 2011
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samplesJournal of Immunological Methods, 2011
- Levels of Antibody against 11 Staphylococcus aureus Antigens in a Healthy PopulationClinical and Vaccine Immunology, 2010
- Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Staphylococcus aureus Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human NeutrophilsPLOS Pathogens, 2010
- Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactionsBMC Microbiology, 2010